Introduction
Perinatal hypoxic-ischemic (H-I) brain injury is a common cause of neurological deficits in children (Chang and Huang, 2006) . The mechanisms of H-I-induced brain damage are heterogeneous. A complex series of pathological events including apoptosis, inflammation, oxidative stress and excitotoxicity after H-I injury are known to precipitate neuronal demise and subsequent neurological dysfunction (Benjelloun et al., 1999; Blomgren and Hagberg, 2006; Johnston, 2005; Northington et al., 2001 ). H-I lesion to the brain has been shown to result in earlier acute necrotic neuronal death in the core of the infarction, followed by a delayed but prolonged apoptotic-like neuronal death in the surrounding zone (Nakajima et al., 2000; Northington et al., 2001) . A rapidly expanding body of evidence also indicates that cerebral inflammation, characterized by activation of microglia and macrophages, leukocyte infiltration, release of pro-inflammatory cytokines, and increased expression of endothelial adhesion molecules (Barone and Feuerstein, 1999; del Zoppo et al., 2000) , also contributes substantially to the pathogenesis of perinatal H-I brain injury (Benjelloun et al., 1999) . The synergistic actions of these pathological processes exacerbate brain injury, leading to deterioration of neurological functions (Barone and Feuerstein, 1999) . Therefore, therapeutic strategies that can target multiple mechanisms could be extremely useful in limiting post-H-I neuronal damage.
Ethyl pyruvate (EP) is a stable lipophilic ester derivative of pyruvate. EP was initially reported to ameliorate structural and functional damage associated with mesenteric ischemia and reperfusion in rats (Sims et al., 2001) . Subsequent in vivo studies documented therapeutic benefits of EP in experimental models of many illnesses, such as coronary ischemia and reperfusion injury (Woo et al., 2004) , hemorrhagic shock (Tawadrous et al., 2002; Yang et al., 2002) , severe sepsis (Ulloa et al., 2002; Zhang et al., 2009) , and acute pancreatitis (Yang et al., 2004b (Yang et al., , 2008 . The neuroprotective effect of EP was also observed in post-ischemic brain using an adult rat model of middle cerebral artery occlusion (MCAO) (Kim et al., 2005; Yu et al., 2005) . The effect of EP in immature brain after H-I, however, is unknown. Multiple mechanisms such as metabolic augmentation, inflammatory response suppression and radical scavenging have been suggested to be involved in the protective effect of EP (Kim et al., 2008; Tokumaru et al., 2009 ). However, the specific molecular target of EP that produces neuroprotection remains to be elucidated. 
